Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 429-435

  Hall, Brandon J ^a,b   Pearson, Laura S ^b   Buccafusco, Jerry J ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

24 h access; BTMPS; Nicotine; Nicotinic acetylcholine receptor antagonist; Operant testing; Recidivism; Self administration; Substance abuse; Withdrawal

Indexed keywords

BIS(2,2,6,6 TETRAMETHYL 4 PIPERIDINYL)SEBACATE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ABSTINENCE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG INTERMITTENT THERAPY; DRUG SELF ADMINISTRATION; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; TOBACCO DEPENDENCE;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CONDITIONING, OPERANT; DECANOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; MALE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REWARD; SELF ADMINISTRATION; SPACE PERCEPTION; TIME FACTORS; TOBACCO USE CESSATION;

EID: 72049119353     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.09.009     Document Type: Article

References (30)

1. Aston-Jones G., and Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 (2004) 167-179
2. Bongiovanni M., and See R.E. A comparison of the effects of different operant training experiences and dietary restriction on the reinstatment of cocaine-seeking in rats. Pharmacol. Biochem. Beh. 89 (2008) 227-233
3. Bruijnzeel D.H., and Markou A. Adaptations in cholinergic transmission associated with the affective signs of nicotine withdrawal. Neuropharmacology 47 (2004) 572-579
4. Buccafusco J.J., Davis J., Shuster L., Buccafusco C.J., and Gattu M. The importance of brainstem cholinergic neurons in the pressor response to cocaine. J. Pharmacol. Exp. Ther. 312 (2005) 179-191
5. Buccafusco J.J., and Bain J.N. A 24-h access i.v. self-administration schedule of nicotine reinforcement and the estimation of recidivism: pharmacological modification by arecoline. Neuroscience 149 (2007) 487-498
6. Chadman K.K., and Woods J. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon. J. Pharmacol. Exp. Ther. 308 (2004) 73-78
7. Cox B., Goldstein A., and Nelson W. Nicotine self-administration in rats. Br. J. Pharmacol. 83 (1984) 49-55
8. Damaj M.I., Kao W., and Martin B.R. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J. Pharmacol. Exp. Ther. 307 (2003) 526-534
9. Damaj M.I., Fonk C., Marks M.J., Deshpande P., Labarca C., Lester H.A., Collins A.C., and Martin B.R. Genetic approaches identify differential roles for α4ß2* nicotinic receptors in acute models of antinociception in mice. J. Pharmacol. Exp. Ther. 321 3 (2007) 1161-1169
10. Flores C.M., Rogers S., Pabreza L., Wolfe B., and Kellar K. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 41 (1992) 31-37
11. Glover E.D., Laflin M.T., Schuh K.J., et al. A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. Addiction 102 5 (2007) 795-802
12. Gonzales D., Rennard S.I., Nides M., Oncken C., Azoulay S., Billing C.B., et al. Varenicline, an α4ß2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. J. Am. Med. Assoc. 296 (2006) 47-55
13. Graham J., Papke R., and Buccafusco J.J. Functional central nicotinic acetylcholine receptor antagonism by systemic administration of Tinuvin 770 (BTMPS). Curr. Alzheimer Res. 2 (2005) 141-147
14. Hildebrand B., Nomikos G.G., Bondjers C., Nisell M., and Svensson T.H. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology 129 (1997) 348-356
15. Jackson K.J., Martin B.R., Changeux J.P., and Damaj M.I. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J. Pharmacol. Exp. Ther. 325 1 (2008) 302-312
16. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
17. Malin D.H., Lake J., Newlin-Maultsby P., Roberts L., Lanier J., Carter V., Cunningham J., and Wilson O. Rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 43 (1992) 779-784
18. Markou A., Kosten T., and Koob G.F. Neurobiological similarities in depression and drug dependence: a self medication hypothesis. Neuropsychopharmacology 18 (1998) 135-174
19. Matta S.G., Balfour D.J., Benowitz N.L., Boyd T., Buccafusco J.J., Caggiula A.R., Craig C.R., Collins A.C., Damaj M.I., Donny E.C., Gardiner P.S., Grady S.R., Heberlein U., Leonard S.S., Levin E.D., Lukas R.J., Markou A., Marks M.J., McCallum S.E., Parameswaran N., Perkins K.A., Picciotto M.R., Quik M., Rose J.E., Rothenfluh A., Schafer W.R., Stolerman I.P., Tyndale R.F., Wehner J.M., and Zirger J.M. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190 (2007) 269-319
20. O'Dell L., Chen S., Smith R., Specio S., Balster R., Paterson N., Markou A., Zorrilla E., and Koob G. Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats. J. Pharmacol. Exp. Ther. 320 1 (2007) 180-193
21. Papke R.L., Craig G., and Heinemann S. Inhibition of nicotinic acetylcholine receptors by bis (2,2,6,6-tetratmethyl-4-piperidinyl) sebacate (Tinuvin 770), an additive to chemical plastics. J. Pharmacol. Exp. Ther. 268 2 (1994) 718-726
22. Paterson N.E., and Markou A. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl) 173 (2004) 64-72
23. Salas R., Sturm R., Boulter J., and De Biasi M. Nicotinic receptors in the habenulo-interpeduncular system necessary for nicotine withdrawal in mice. J. Neurosci. 29 10 (2009) 3014-3018
24. Shalev U., Grimm J., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol. Rev. 54 (2002) 1-42
25. Stapleton J. Cigarette smoking prevalence, cessation and relapse. Stat. Methods Med. Res. 7 2 (1998) 187-203
26. Siu E., and Tyndale R.F. Non-nicotinic therapies for smoking cessation. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 541-564
27. Valentine J.D., Hokanson J., Matta S., and Sharp B. Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl) 133 (1997) 300-304
28. Varanda W.A., Aracava Y., Sherby S.M., et al. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mel PharmacoZ 28 (1985) 128-137
29. Wing V.C., and Shoaib M. Contextual stimuli modulate extinction and reintroduction in rodents self-administering intravenous nicotine. Psychopharmacology 200 (2008) 357-365
30. Young J.M., Shytle R., Sanberg R., and George T. Mecamylamine: new therapeutic uses and toxicity/risk profile. Clin. Ther. 23 (2001) 532-565